What's new

Human medicines European public assessment report (EPAR): Lorviqua, lorlatinib, Date of authorisation: 06/05/2019, Revision: 15, Status: Authorised

Human medicines European public assessment report (EPAR): Lorviqua, lorlatinib, Date of authorisation: 06/05/2019, Revision: 15, Status: Authorised

May 15, 2025 - 15:54
 0
Human medicines European public assessment report (EPAR): Lorviqua, lorlatinib, Date of authorisation: 06/05/2019, Revision: 15, Status: Authorised
Human medicines European public assessment report (EPAR): Lorviqua, lorlatinib, Date of authorisation: 06/05/2019, Revision: 15, Status: Authorised
Read More

Tags:

Previous Article

Human medicines European public assessment report (EPAR): Enspryng, satralizumab...

Next Article

The NATO Internship Programme is now open for applications!

Related Posts

Supporting innovation

Supporting innovation

May 8, 2025  0

PSUSA/00010464/202407

PSUSA/00010464/202407

May 6, 2025  0

Fourteenth meeting of the industry stakeholder platform on the operation of the centralised procedure for human medicines, Online, European Medicines Agency, Amsterdam, the Netherlands, from 23 June 2025, 13:00 (CEST) to 23 June 2025, 18:00 (CEST)

Fourteenth meeting of the industry stakeholder platform...

May 15, 2025  0